Sun Pharmaceutical Industries Limited has informed the Exchange about press release dated 09-Nov-2022 titled Sun Pharma and SPARC enter into a license agreement for commercialization of phenobarbital for injection in the US
Press Release Nov 09 2022
Filed with NSE ·
6ix hasn’t read this filing yet.
Sun Pharmaceutical Industries Limited on 6ix
Earlier from Sun Pharmaceutical Industries
- Press Release Nov 01 2022
- Press Release Oct 11 2022
- Press Release Aug 03 2022
- Press Release Jul 29 2022
- Press Release Jul 26 2022
Later from Sun Pharmaceutical Industries
- Press Release Nov 18 2022
- Sun Pharmaceutical Industries Limited - SEZABY approved by US FDA for the treatment of neonatal seizures
- Sun Pharmaceutical Industries Limited Press Release Jan 11 2023
- Press Release Jan 17 2023
- Press Release Jan 25 2023
Follow Sun Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Sun Pharmaceutical Industries